The Localization of Aluminum in Bone: Implications for the Mechanism of Fixation and for the Pathogenesis of Aluminum-Related Bone Disease

Ott S.M. Aluminum-related osteomalacia. Int J of Artificial Organs 1983; 6: 173–5.

Burnatowska-Hledin M.A. , Kaiser K. , Mayor G.H. Aluminum, parathyroid hormone, and osteomalacia. Special Topics in Endrocrinology and Metabolism 1983; 5: 201–26.

Norris K.C. , Crooks P.W. , Nebeker HG . Clinical and laboratory features of aluminum-related bone disease: Differences between sporadic and “epidemic” forms of the syndrome. Am J Kidney Dis 1985; 6: 342–7.

DeBroe M.E. , Vand de Vyver F.L. , eds. Aluminum: A clinical problem in nephrology. Clin Nephrol 1985; 24(suppl 1): S1–S104.

Coburn J.W. , Alfrey A.C. , eds. Conference on aluminum related disease. Kid Int 1986; 29(Supp 18); S1–S123.

Smith A.J. , Faugere M-C , Abreo K. , Fanti P. , Julian M. , Malluche H.H. Aluminum-related bone disease in mild and advanced renal failure: Evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol 1986; 6: 275–83.

Nebeker H.G. , Coburn J.W. Aluminum and renal osteodystrophy. Ann Rev Med 1986; 37: 79–95.

Quarles L.D. , Gitelman H.J. , Drezner M.K. Aluminum-associated bone disease: What's in a name? J Bone Min Res 1986; 1: 389–90.

Boyce B.F. , Elder H.Y. , Fell GS . Quantitation and localisation of aluminum in human cancellous bone in renal osteodystrophy. Scanning Electron Microscopy 1981; 3: 329–37.

Cournot-Witmer G. , Zingraff J. , Plachot JJ . Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization. Kidney Int 1981; 20: 375–85.

Buchanan M.R.C. , Ihle B.U. , Dunn C.M. Haemodialysis related osteomalacia: a staining method to demonstrate aluminium. J Clin Pathol 1981; 34: 1352–4.

Maloney N.A. , Ott S.M. , Alfrey A.C. , Miller N.L. , Coburn J.W. , Sherrad D.J. Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 1982: 206–16.

Smith P.S. , McClure J. Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy. J Clin Pathol 1982; 35: 1283–93.

Parfitt A.M. The cellular basis of bone remodeling. The quantum concept reexamined in light of recent advances in cell biology of bone. Calc Tissue Int 1984; 36: S37–45.

Eriksen E.F. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endrocrine Reviews 1986; 7: 379–408.

Chambers T.J. , Darby J.A. , Fuller K. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res 1985; 241: 671–5.

Villanueva A.R. , Sypitkowski C. , Parfitt A.M. A new method for identification of cement lines in undecalcified, plastic embedded sections of bone. Stain Technol 1986; 61: 83–8.

Malluche H.H. , Faugere M-C . Atlas of mineralized bone histology. Basel: Karger, 1986.

Parfitt A.M. , Drezner M.K. , Glorieux F.H. Bone histomorphometry nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Min Res 1981; 2: 595–610.

Villanueva A.R. , Kujawa M. , Mathews C.H.E. , Parfitt A.M. Identification of the mineralization front: Comparison of a modified toluidine blue stain with tetracycline fluorescence. Metab Bone Dis & Rel Res 1983; 5: 41–5.

Milliner D.S. , Nebeker H.G. , Ott SM . Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Intern Med 1984; 101: 775–80.

Berland Y. , Charhon S.A. , Olmer M. , Meunier P.J. Predictive value of desferrioxamine infusion test for bone aluminum deposits in hemodialyzed patients. Nephron 1985; 40: 433–5.

Hodsman A.B. , Hood S.A. , Brown P. , Cordy P.E. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine? J Lab Clin Med 1985; 106: 674–81.

McCarthy J.T. , Kurtz S.B. , McCall J.T. Elevated bone aluminum content in dialysis patients without osteomalacia. Mayo Clin Proc 1985; 60: 315–20.

Faugere M-C , Malluche H.H. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int 1986; 30: 717–22.

Verbeuken A.H. , Van de Vyver F.L. , Van Grieken RE . Ultrastructural localization of aluminum in patients with dialysis-associated osteomalacia. Clin Chem 1984; 30: 763–8.

Ott S.M. , Maloney N.A. , Coburn J.W. , Alfrey A.C. , Sherrard D.J. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 1982; 307: 709–13.

Denton J. , Freemont A.J. , Ball J. Detection and distribution of aluminium in bone. J Clin Pathol 1984; 37: 136–42.

Echlin P. , ed. Analysis of organic and biological surfaces. New York: John Wiley and Sons, 1984.

Plachot J-J , Cournot-Witmer G. , Halpern S . Bone ultrastructure and x-ray microanalysis of aluminum-intoxicated hemodialyzed patients. Kidney Int 1984; 25: 796–803.

Bauer T.W. , Popowniak K.L. , Stulberg B.N. , McMahon J.T. Osteomalacia associated with aluminum intoxication in a patient with chronic renal failure. Cleve Clin Q 1985; 52: 271–8.

Verbeuken A.H. , Van de Vyver F.L. , Visser W.J. , Van Grieken R.E. , DeBroe M.E. Laser microprobe mass analysis (LAMMA) to verify the aluminum staining of bone. Stain Technology 1986; 61: 287–95.

Charhon S.A. , Berland Y.F. , Olmer M.J. , Delawari E. , Traeger J. , Meunier P.J. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients. Kidney Int 1985; 27: 426–35.

Hodsman A.B. , Anderson C. , Leung F.Y. Accelerated accumulation of aluminum by osteoid matrix in vitamin D deficiency. Mineral Electrolyte Metab 1984; 10: 309–15.

Quarles L.D. , Dennis V.W. , Gitelman H.J. , Harrelson J.M. , Drezner M.K. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs. J Clin Invest 1985; 75: 1441–7.

Sypitkowski C. , Stanciu J. , Villanueva A.R. , Parfitt A.M. Relationship between iron and aluminum in bone from dialysis patients. Abstracts of Conference on Aluminum-Related Disease: Pathogenesis, Recognition, Treatment, and Prevention, June 18-20, 1984.

Kaye M. Bone marrow aluminium storage in renal failure. J Clin Pathol 1983; 36: 1288–91 (and correspondence, 1984; 37: 837–8).

Bommer J. , Waldherr R. , Wieser P-H , Eberhard Ritz . Concomitant lysosomal storage of iron and aluminium in dialysis patients. Lancet 1983; i: 1390.

O'Connor M. , Garrett P. , Dockery M . Aluminum-related bone disease. Am J Clin Pathol 1986; 86: 168–74.

Andress D.L. , Maloney N.A. , Coburn J.W. , Endres D.B. , Sherrard D.J. Osteomalacia and apalstic bone disease in aluminum-related osteodystrophy. J Clin Endrocrinol Metab 1987; 65: 11–6.

Parfitt A.M. Terminology and symbols in bone morphometry. In: Jaworski Z.F.G. , ed. Proceedings of the First International Workshop on Bone Morphometry. Ottawa, Ottawa University Press, 1976; 331–5.

Boskey A.L. , Bullough P.G. , Dmitrovsky E. The biochemistry of the mineralization front. In: Jee W.S.S. , Parfitt A.M. eds. Bone histomorphometry. Third International Workshop. Paris: Armour Montagu, 1981; 61–7.

Parfitt A.M. The physiologic and clinical significance of bone histomorphometric data. In: Recker R. , ed. Bone histomorphometry. Techniques and interpretations. Boca Raton: CRC Press, 1983; 143–223.

Cournot-Witmer G. , Plachot J-J , Bourdeau A . Effect of aluminum on bone and cell localization. Kidney Int 1986; 29(suppl 18): S37–40.

Bonucci E. , Matrajt H. , Tunchot S. , Hioco D.J. Bone structure in osteomalacia with special reference to ultrastructure. J Bone Joint Surg 1969; 51B: 511–27.

Sherrard D. , Ott S. , Maloney N. , Andress D. , Coburn J. Uremic osteodystrophy: Classification, cause and treatment. In: Frame B. , Potts J.T. Jr. eds. Clinical disorders of bone and mineral metabolism. Amsterdam: Excerpta Medica, 1983; 254–9.

Dunstan C.R. , Hills E. , Norman AW . The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus. Q J Med 1985; 55: 127–44.

Andress D.L. , Maloney N.A. , Endres D.B. , Sherrard D.J. Aluminum-associated bone disease in chronic renal failure: High prevalence in long-term dialysis population. J Bone Min Res 1986; 1: 391–8.

Parfitt A.M. , Rao D. , Stanciu J. , Villanueva A.R. Comparison of aluminum related with vitamin D related osteomalacia by tetracycline based bone histomorphometry. In: Massry S.G. , Olmer M. , Ritz E. , eds. Phosphate and mineral homeostasis. Adv Exp Med Biol 1986; 208: 283–7.

Parfitt A.M. The cellular mechanisms of osteoid accumulation in metabolic bone disease. In: Mineral metabolism research in Italy. Milano: Wichtig Editore, 1984; 4: 3–9.

Parfitt A.M. Osteomalacia and related disorders. In: Avioli L.V. , Krane S.M. , eds. Metabolic bone disease, 2nd ed. New York: Grune and Stratton (in press).

Meisen F. , Mosekilde L. , Kragstrup J. Metabolic bone diseases as evaluated by bone histomorphometry. In: Recker ed. Bone histomorphometry: techniques and interpretation. Boca Raton: CRC Press, 1983: 265–84.

Meunier P.J. , Van Linthoudt D. , Edouard C. , Charhon S. , Arlot M. Histological analysis of the mechanisms underlying pathogenesis and healing of osteomalacia. Proc Sixteenth European Calc Tiss Sympos 1981; 77: 1–4.

Pødenphant J. , Heaf J.G. , Joffe P. Metabolic bone disease and aluminium contamination in 38 uremic patients. Acta Path Microbiol Immunol Scand Sect A 1986; 94: 1–6.

de Vernejoul M.C. , Belenguer R. , Halkidou H. , Buisine A. , Bielakoff J. , Miravet L. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts. Bone 1985; 6: 15–20.

Boyce B.F. , Elder H.Y. , Elliott HL . Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet 1982; ii: 1009–13.

Olmer M. , Berland Y. , Toga M. , Charhon S. Hyperparathyroidism and bone aluminum deposits may coexist. Contr Nephrol 1985; 49: 38–44.

Charhon S.A. , Chavassieux P.M. , Chapuy M.C. , Boivin G.Y. , Meunier P.J. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. J Lab Clin Med 1985; 106: 123–31.

Delmez J.A. , Fallon M.D. , Harter H.R. , Hruska K.A. , Slatopolsky E. , Teitelbaum S.L. Does strict phosphorus control precipitate renal osteomalacia? J Clin Endrocrinol Metab 1986; 62: 747–52.

Nilsson P. , Meisen F. , Malmaeus J. , Danielson B.G. , Mosekilde L. Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis. Bone 1985; 6: 21–7.

Dunstan C.R. , Evans R.A. Aluminum and renal bone disease in Australia. Kidney Int 1986; 29(suppl 18): S65–9.

Ihle B. , Buchanan M. , Stevens B . Aluminum associated bone disease: Clinico-pathologic correlation. Am J Kid Dis 1982; 2: 255–263.

Ellis H.A. Aluminum induced osteomalacia in patients with chronic renal failure and in animals. Nieren- und Hochdruckkrankheiten 1983; 12: S. 198–206.

McClure J. , Fazzalari N.L. , Fassett R.G. , Pugsley D.J. Bone histoquantitative findings and histochemical staining reactions for aluminum in chronic renal failure patients treated with haemodialysis fluids containing high and low concentrations of aluminium. J Clin Pathol 1983; 36: 1281–7.

McClure J. , Fazzalari N.L. , Fassett R.G. , Pugsley P.G. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid. J Clin Pathol 1984; 37: 743–7.

Ihle B.U. , Buchanan M.R.C. , Stevens B. , Becker G.J. , Kincaid-Smith P. The efficacy of various treatment modalities on aluminium associated bone disease. Proc Eur Dial Transpl Assoc 1982; 19: 195–201.

Malluche H.H. , Smith A.J. , Abreo K. , Faugere M-C . The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure. N Engl J Med 1984; 311: 140–4.

Ott S.M. , Andress D.L. , Nebeker H.G. , Milliner D.S. , Maloney N.A. , Coburn J.W. , Sherrard D.J. Changes in bone histology after treatment with desferrioxamine. Kidney Int 1986; 29(suppl 18): S108–13.

Andress D.L. , Nebeker H.G. , Ott SM . Bone histologic response to deferoxamine in aluminum-related bone disease. Kidney Int 1987; 31: 1344–50.

Pødenphant J. , Salem N. , Sypitkowski C. , Frame B. , Parfitt A.M. Reversal of aluminum related dialysis osteomalacia after transpalantation. Proc Fourth International Workshop on Bone Histomorphometry. Bone 1985; 6: 405.

Parfitt A.M. Are bone problems of dialysis patients always solved by renal transplantation? A CPC Series: Cases in Metabolic Bone Disease 1, No. 4, 1986. New York: Medical Projects Inc.

Blumenthal N.C. , Posner A.S. In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth. Calcif Tissue Int 1984; 36: 439.

Thomas W.C. , Meyer J.L. Aluminum-induced osteomalacia: an explanation. Am J Nephrol 1984; 4: 201–3.

Chan Y.K. , Alfrey A.C. , Posen S . Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int 1983; 35: 344–51.

Goodman W.G. Short-term aluminum administration in the rat: Reductions in bone formation without osteomalacia. J Lab Clin Med 1984; 103: 749–57.

Goodman W.G. , Henry D.A. , Horst R. , Nudelman R.K. , Alfrey A.C. , Coburn J.W. Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney Int 1984; 25: 370–5.

Finch J.L. , Bergfeld M. , Martin K.J. , Chan Y-L , Teitelbaum S. , Slatopolsky E. The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia. Kidney Int 1986; 30: 318–24.

Ott S.M. , Feist E. , Andress DL . Development and reversibility of aluminum-induced bone lesion in the rat. J Lab Clin Med 1987; 109: 40–7.

Sedman A.B. , Alfrey A.C. , Miller N.L. , Goodman W.G. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig. J Clin Invest 1987; 79: 86–92.

Hodsman A.B. , Sherrard D.J. , Alfrey AC . Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 1982; 54: 539–46.

Dunstan C.R. , Evans R.A. , Hills E. , Wong S.Y.P. , Alfrey A.C. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure. Calcif Tissue Int 1984; 36: 133–8.

Faugere M.C. , Arnala I.O. , Ritz E. , Malluche H.H. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis. J Lab Clin Med 1986; 107: 481–7.

Slatopolsky E. The interaction of parathyroid hormone and aluminum in renal osteodystrophy. Kidney Int 1987; 31: 842–54.

Charhon S.A. , Chavassieux P.M. , Chapuy M.C. , Traeger J. , Meunier P.J. High bone turnover associated with an aluminum-induced impairment of bone mineralization. Bone 1986; 7: 319–24.

Canalis E. Effect of growth factors on bone cell replication and differentiation. Clin Orthop 1985; 183: 246–63.

Andress D.L. , Ott S.M. , Maloney N.A. , Sherrard D.J. Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. N Engl J Med 1985; 312: 468–73.

de Vernejoul M.C. , Marchais S. , London G. , Morieux C. , Bielakoff J. , Miravet L. Increased bone aluminum deposition after subtotal parathyroidectomy in dialyzed patients. Kidney Int 1985; 27: 785–91.

Andress D.L. , Kopp J.B. , Maloney N.A. , Coburn J.W. , Sherrard D.J. Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 1987; 316: 292–6.

Alfrey A.C. , Sedman A. , Chan Y-L . The compartmentalization and metabolism of aluminum in uremic rats. J Lab Clin Med 1985; 105: 227–33.

Quarles L.D. , Gitelman H.J. , Dennis V.W. , Drezner M.K. Parathyroid hormone deficiency: Effects on aluminum induced bone disease. Kid Int 1987; 31: 356 (Abstract).

Parfitt A.M. , Villnueva A.R. , Mathews C.H.E. , Aswani J.A. Kinetics of matrix and mineral apposition in osteoporosis and renal osteodystrophy: Relationship to rate of turnover and to cell morphology. In: Jee W.S.S. , Parfitt A.M. , eds. Bone histomorphometry: Third International Workshop, Paris: Armour-Montagu 1981; 213–19.

Parfitt A.M. Bone and plasma calcium homeostasis. Bone 1987; 8: 51–8.

Sherrard D.J. , Ott S.M. , Andress D.L. Pseudohyperparathyroidism. Syndrome associated with aluminum intoxication in patients with renal failure. Am J Med 1985; 79: 127–30.

Quarles L.D. , Gitelman H.J. , Harrelson J.M. , Dennis V.W. , Drezner M.K. Bone aluminum: A non-essential determinant of aluminum induced osseous disease. J Bone Min Res 1986; 1(Supp 1), Abstract No. 164.